Novo Nordisk Says Ozempic Drug Cuts Risk of Kidney Problems
Novo Nordisk’s blockbuster weight-loss drug cuts the risk of kidney disease-related events in diabetic patients by 24%, according to a new clinical trial conducted by the company.
Novo Nordisk’s blockbuster weight-loss drug cuts the risk of kidney disease-related events in diabetic patients by 24%, according to a new clinical trial conducted by the company.
FOLLOW US ON GOOGLE NEWS
Read original article here
Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each…